山﨑悦子 (Etsuko Yamazaki) - マイポータル

基本情報

所属: 独立行政法人労働者健康安全機構　横浜労災病院　血液内科部長

学位: 医学博士(横浜市立大学)

J-GLOBAL ID: 201201061502266481
researchmap会員ID: 7000002289

外部リンク: http://www.yokohama-cu.ac.jp/fukuhp/section/central_section/laboindex.html

筑波大学医学専門学群、横浜市立大学大学院医科学研究科卒業。
血液内科医として研鑚を積み、2015年からは臨床検査部部長として臨床検査分野においても研鑚を積んでいる。

研究キーワード

検査血液学

論文

Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation

Haruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, Satoshi Koyama, Hiroyuki Takahashi, Yuki Nakajima, Hiroyoshi Kunimoto, Takayoshi Tachibana, Takuya Miyazaki, Kenji Matsumoto …

Hematology 27(1) 620-628 2022年12月31日
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.

Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu Tsuzuki, Hiroo Ueno, Eisuke Iwamoto, Yuka Iijima-Yamashita, Tomomi Yamada, Takashi Kanamori …

Blood 139(12) 1850-1862 2022年3月24日
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.

Takeshi Saito, Yoshihiro Hatta, Fumihiko Hayakawa, Tsutomu Takahashi, Maki Hagihara, Hiroatsu Iida, Koichiro Minauchi, Etsuko Yamazaki, Isamu Sugiura, Tohru Murayama …

International journal of hematology 113(3) 395-403 2021年3月
Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7

Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, Junji Ikeda, Hiroshi Teranaka, Ikuma Kato, Takuya Miyazaki, Makiko Enaka, Takayuki Mitsuhashi, Etsuko Yamazaki …

HemaSphere 4(5) e469-e469 2020年10月
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.

Taiki Ando, Shin Fujisawa, Haruka Teshigawara, Ayako Matsumura, Takayuki Sakuma, Taisei Suzuki, Hiroshi Teranaka, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita …

International journal of hematology 112(1) 46-56 2020年7月
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.

Taiki Ando, Shin Fujisawa, Haruka Teshigawara, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita, Kenji Motohashi, Takuya Miyazaki, Takayoshi Tachibana, Maki Hagihara …

International journal of hematology 109(6) 673-683 2019年6月
Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation.

Satoshi Koyama, Hiroyuki Fujita, Takeshi Shimosato, Aki Kamijo, Yasufumi Ishiyama, Eri Yamamoto, Yoshimi Ishii, Yukako Hattori, Maki Hagihara, Etsuko Yamazaki …

Probiotics and antimicrobial proteins 11(1) 295-298 2019年3月
細胞障害性の表現型を呈する末梢性T細胞リンパ腫の後方視的検討(Peripheral T-cell lymphoma of cytotoxic phenotype: a retrospective case series)

高橋寛行, 佐久間敬之, 勅使川原晴佳, 松村彩子, 根来暁子, 中嶋ゆき, 江中牧子, 宮崎拓也, 萩原真紀, 松本憲二 …

臨床血液 59(9) 1548-1548 2018年9月
DeVIC療法が奏功したBlastic plasmacytoid dendritic cell neoplasm(Blastic plasmacytoid dendritic cell neoplasm treated with DeVIC therapy: a case report)

佐久間敬之, 高橋寛行, 勅使川原晴佳, 松村彩子, 根来暁子, 中嶋ゆき, 江中牧子, 宮崎拓也, 萩原真紀, 松本憲二 …

臨床血液 59(9) 1659-1659 2018年9月
当院における低悪性度リンパ腫に対するベンダムスチンの使用成績(Outcome of bendamustine for indolent B cell lymphoma: a single-center retrospective study)

松本憲二, 佐久間敬之, 勅使川原晴佳, 松村彩子, 根来暁子, 高橋寛行, 中嶋ゆき, 宮崎拓也, 萩原真紀, 山崎悦子 …

臨床血液 59(9) 1722-1722 2018年9月
マクログロブリン血症を伴うC-MYC/IgH転座陽性低悪性度B細胞リンパ腫

徳永真由美, 高橋寛行, 勅使川原晴佳, 松村彩子, 中嶋ゆき, 江中牧子, 宮崎拓也, 萩原真紀, 松本憲二, 山崎悦子 …

臨床血液 58(11) 2275-2275 2017年11月
Body mass index is a prognostic factor in adult patients with acute myeloid leukemia

Taiki Ando, Etsuko Yamazaki, Eriko Ogusa, Yoshimi Ishii, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto, Masatsugu Tanaka …

INTERNATIONAL JOURNAL OF HEMATOLOGY 105(5) 623-630 2017年5月査読有り
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia

Etsuko Yamazaki, Heiwa Kanamori, Megumi Itabashi, Eriko Ogusa, Ayumi Numata, Wataru Yamamoto, Satomi Ito, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto …

LEUKEMIA & LYMPHOMA 58(1) 104-109 2017年査読有り
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma

Naoto Tomita, Taisei Suzuki, Kazuho Miyashita, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Hirotaka Takasaki, Rika Kawasaki, Maki Hagihara, Chizuko Hashimoto …

LEUKEMIA & LYMPHOMA 57(12) 2763-2770 2016年12月査読有り
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.

山崎悦子

Leukemia & Lymphoma 7 1-6 2016年6月査読有り
[Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].

Miyazaki T, Abe N, Yamazaki E, Koyama S, Miyashita K, Takahashi H, Nakajima Y, Tachibana T, Kamijo A, Tomita N …

[Rinsho ketsueki] The Japanese journal of clinical hematology 57(2) 180-185 2016年2月査読有り
Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia

Takayoshi Tachibana, Masatsugu Tanaka, Maki Hagihara, Rika Kawasaki, Etsuko Yamazaki, Hideyuki Koharazawa, Jun Taguchi, Naoto Tomita, Katsumichi Fujimaki, Rika Sakai …

INTERNATIONAL JOURNAL OF HEMATOLOGY 102(4) 451-459 2015年10月査読有り
ボルテゾミブとデキサメタゾンの併用による寛解導入療法を施行した移植適応新規骨髄腫症例における予後規定因子の検討

小原澤英之, 渡邊玲奈, 服部友歌子, 沼田歩, 川崎理加, 桑原英幸, 萩原真紀, 松本憲二, 田中正嗣, 橋本千寿子 …

臨床血液 56(4) 392-399 2015年4月
サリドマイドが奏功し、自家末梢血幹細胞移植後に完全寛解を得た原発性形質細胞性白血病の1例

酒井リカ, 橋本千寿子, 山崎悦子, 青島朋裕, 松浦史郎, 山本渉, 藤田敦子, 大島理加, 兵理絵, 桑原英幸 …

臨床血液 49(9) 1134-1134 2008年9月
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia

Hideyuki Koharazawa, Heiwa Kanamori, Rika Sakai, Chizuko Hashimoto, Sachiya Takemura, Etsuko Yamazaki, Michiko Hattori, Jun Taguchi, Katsumichi Fujimaki, Naoto Tomita …

LEUKEMIA & LYMPHOMA 49(11) 2133-2140 2008年査読有り

もっとみる

MISC

Corynebacterium blood stream infection among hematological malignancy patients with neutropenia: a case series analysis

Hiroyuki Takahashi, Hideaki Kato, Ayako Matsumura, Kazuho Miyashita, Sei Samukawa, Yuki Nakajima, Maki Hagihara, Etsuko Yamazaki, Shin Fujisawa, Hideaki Nakajima

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 50 S60-S60 2017年11月
Impact of the Difference in Body Mass Index at Transplantation from That at Diagnosis for Graft-Versus-Host Disease-Free, Relapse-Free Survival in Acute Myeloid Leukemia

Taiki Ando, Etsuko Yamazaki, Haruka Teshigawara, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita, Kenji Motohashi, Takuya Miyazaki, Takayoshi Tachibana, Maki Hagihara …

BLOOD 128(22) 2016年12月
クローンの相同性が示唆された、未分化大細胞T細胞リンパ腫合併低悪性度T細胞白血病の1例

高橋寛行, 萩原真紀, 勅使川原晴佳, 松村彩子, 三宅暁夫, 中嶋ゆき, 江中牧子, 宮崎拓也, 松本憲二, 山崎悦子 …

臨床血液 57(11) 2428-2428 2016年11月
The Sil Index Is a Useful Prognostic Indicator for Diffuse Large B-Cell Lymphoma

Naoto Tomita, Taisei Suzuki, Kazuho Miyashita, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Hirotaka Takasaki, Rika Kawasaki, Maki Hagihara, Chizuko Hashimoto …

BLOOD 126(23) 2015年12月
Body Mass Index Is a Prognostic Factor in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Multi-Institutional Study in Japan

Taiki Ando, Etsuko Yamazaki, Haruka Teshigawara, Fujii Eriko, Yoshimi Ishii, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto …

BLOOD 126(23) 2015年12月
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy

Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Yoshimi Ishii, Yuki Nakajima, Ayumi Numata, Yukako Hattori, Wataru Yamamoto …

LEUKEMIA RESEARCH 39(11) 1187-1191 2015年11月
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma

Naoto Tomita, Masataka Taguri, Chizuko Hashimoto, Hirotaka Takasaki, Katsumichi Fujimaki, Shigeki Motomura, Hideyuki Koharazawa, Sachiya Takemura, Hiroyuki Fujita, Etsuko Yamazaki …

ANNALS OF HEMATOLOGY 94(11) 1935-1937 2015年11月
R-CHOP therapy alone for limited-stage follicular lymphoma

Naoto Tomita, Taisei Suzuki, Yasufumi Ishiyama, Kazuho Miyashita, Hiroyuki Takahashi, Ayumi Numata, Satomi Ito, Kenji Motohashi, Takayoshi Tachibana, Hirotaka Takasaki …

LEUKEMIA RESEARCH 39(6) 582-585 2015年6月
Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy

M. Tanaka, H. Kanamori, K. Matsumoto, T. Tachibana, A. Numata, K. Ohashi, T. Kobayashi, C. Nakaseko, Y. Kanda, E. Yamazaki …

BONE MARROW TRANSPLANTATION 50(5) 727-733 2015年5月
Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy

[Rinshō ketsueki] The Japanese journal of clinical hematology 56 392-399 2015年4月1日
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients

Naoto Tomita, Fumio Kodama, Naoko Tsuyama, Seiji Sakata, Kengo Takeuchi, Daisuke Ishibashi, Satoshi Koyama, Yoshimi Ishii, Wataru Yamamoto, Hirotaka Takasaki …

HEMATOLOGICAL ONCOLOGY 33(1) 9-14 2015年3月
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy

Yuki Nakajima, Naoto Tomita, Megumi Itabashi, Kazuho Miyashita, Reina Watanabe, Takuya Miyazaki, Takayoshi Tachibana, Hirotaka Takasaki, Rika Kawasaki, Masatsugu Tanaka …

LEUKEMIA RESEARCH 39(2) 198-203 2015年2月
No Outcome Differences Were Observed Between Supra-Diaphragmatic and Infra-Diaphragmatic Lesions in Limited-Stage Diffuse Large B Cell Lymphoma Treated with R-CHOP Therapy, Whereas the Presence of Gastro-Intestinal Lesions Was Associated with a Favorable Prognosis

Yuki Nakajima, Naoto Tomita, Megumi Itabashi, Kazuho Miyashita, Reina Watanabe, Takuya Miyazaki, Takayoshi Tachibana, Hirotaka Takasaki, Rika Kawasaki, Masatsugu Tanaka …

BLOOD 124(21) 2014年12月
Beta-2 Microglobulin As a Strong Prognostic Factor in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone

Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Yoshimi Ishii, Ayumi Numata, Yukako Hattori, Wataru Yamamoto, Takuya Miyazaki …

BLOOD 124(21) 2014年12月
Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia: Results From a Randomized Controlled Trial

Katsuji Shinagawa, Masamitsu Yanada, Toru Sakura, Yasunori Ueda, Masashi Sawa, Junichi Miyatake, Nobuaki Dobashi, Minoru Kojima, Yoshihiro Hatta, Nobuhiko Emi …

JOURNAL OF CLINICAL ONCOLOGY 32(33) 3729-+ 2014年11月
Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type

Etsuko Yamazaki, Naoto Tomita, Satoshi Koyama, Eriko Ogusa, Yoshimi Ishii, Hiroyuki Takahashi, Kazuho Miyashita, Shiro Matsuura, Takayoshi Tachibana, Hirotaka Takasaki …

MEDICAL ONCOLOGY 31(9) 1-7 2014年9月
Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type

Etsuko Yamazaki, Naoto Tomita, Satoshi Koyama, Eriko Ogusa, Yoshimi Ishii, Hiroyuki Takahashi, Kazuho Miyashita, Shiro Matsuura, Takayoshi Tachibana, Hirotaka Takasaki …

MEDICAL ONCOLOGY 31(9) 149 2014年9月
The rate of reduction in the maximum standardized uptake value from the initial to the post-R-CHOP therapy in positron emission tomography scan predicts disease progression in diffuse large B cell lymphoma patients

Yoshimi Ishii, Naoto Tomita, Ukihide Tateishi, Yasufumi Ishiyama, Eri Yamamoto, Yukako Hattori, Maki Hagihara, Etsuko Yamazaki, Yoshiaki Ishigatsubo

MEDICAL ONCOLOGY 31(3) 2014年3月
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era

Reina Watanabe, Naoto Tomita, Megumi Itabashi, Daisuke Ishibashi, Eri Yamamoto, Satoshi Koyama, Kazuho Miyashita, Hiroyuki Takahashi, Yuki Nakajima, Yukako Hattori …

EUROPEAN JOURNAL OF HAEMATOLOGY 92(3) 204-210 2014年3月
European treatment and outcome study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Eri Yamamoto, Shin Fujisawa, Maki Hagihara, Masatsugu Tanaka, Katsumichi Fujimaki, Kumiko Kishimoto, Chizuko Hashimoto, Megumi Itabashi, Daisuke Ishibashi, Yuki Nakajima …

Cancer Science 105(1) 105-109 2014年1月

もっとみる